These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 1607702

  • 1. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F, Wattel E, Mariotti M, Agis F, Gordien E, Lefrère JJ.
    J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
    [No Abstract] [Full Text] [Related]

  • 2. [HTLV-I and HTLV-II viruses: fifteen years after their description].
    Delaporte E.
    Med Trop (Mars); 1995 Jul; 55(1):17-20. PubMed ID: 7637602
    [No Abstract] [Full Text] [Related]

  • 3. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991 Jul; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 4. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
    Colombo E, Magistrelli C, Mendozzi E, Cattaneo E, Achilli G, Ferrante P.
    J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
    [Abstract] [Full Text] [Related]

  • 5. Detection and characterization of human T-lymphotropic viruses.
    Calabrò ML, Favero A, Chieco-Bianchi L.
    Antibiot Chemother (1971); 1994 Sep; 46():125-33. PubMed ID: 7826033
    [No Abstract] [Full Text] [Related]

  • 6. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
    Rolo Gómez F, De Armas MB, Mato Luis J, Lubián Caballero AL, Díaz Torres H.
    Rev Cubana Med Trop; 1997 Sep; 49(3):204-8. PubMed ID: 9685988
    [Abstract] [Full Text] [Related]

  • 7. Laboratory study of HIV-1 and HTLV-I/II coinfection.
    Beilke MA, Greenspan DL, Impey A, Thompson J, Didier PJ.
    J Med Virol; 1994 Oct; 44(2):132-43. PubMed ID: 7852953
    [Abstract] [Full Text] [Related]

  • 8. Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns.
    Soriano V, Gutiérrez M, González-Lahoz J.
    J Infect; 1998 Mar; 36(2):243-4. PubMed ID: 9570669
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
    Jõgeda EL, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uusküla A, Lutsar I, Huik K.
    Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
    [Abstract] [Full Text] [Related]

  • 11. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
    Berini CA, Pando MA, Bautista CT, Eirin ME, Martinez-Peralta L, Weissenbacher M, Avila MM, Biglione MM.
    J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
    [Abstract] [Full Text] [Related]

  • 12. The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas.
    Zucker-Franklin D, Pancake BA.
    Semin Dermatol; 1994 Sep; 13(3):160-5. PubMed ID: 7986683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.
    Caterino-de-Araujo A, Alves FA, Campos KR, Lemos MF, Moreira RC.
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(2):130-134. PubMed ID: 29236927
    [Abstract] [Full Text] [Related]

  • 15. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen IS, Lefrère JJ.
    J Infect Dis; 1992 Feb; 165(2):369-72. PubMed ID: 1730903
    [Abstract] [Full Text] [Related]

  • 16. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
    Olaleye OD, Ekweozor CC, Li ZL, Opala IE, Sheng Z, Onyemenem TN, Rasheed S.
    Arch Virol; 1996 Feb; 141(2):345-55. PubMed ID: 8634025
    [Abstract] [Full Text] [Related]

  • 17. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C, Pilotti E, Bertazzoni U.
    AIDS Rev; 2007 Feb; 9(3):140-9. PubMed ID: 17982939
    [Abstract] [Full Text] [Related]

  • 18. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Bailer RT, Lazo A, Harisdangkul V, Ehrlich GD, Gray LS, Whisler RL, Blakeslee JR.
    J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
    [Abstract] [Full Text] [Related]

  • 19. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [Abstract] [Full Text] [Related]

  • 20. HTLV infection in ELISA-negative blood donors.
    Zehender G, Girotto M, De Maddalena C, Francisco G, Moroni M, Galli M.
    AIDS Res Hum Retroviruses; 1996 May 20; 12(8):737-40. PubMed ID: 8744584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.